María José Ortuño Romero, PhD
DownloadHi-Res Photo
Cards
Appointments
Genetics
Primary
Contact Info
About
Titles
Associate Research Scientist in Genetics
Appointments
Genetics
Associate Research ScientistPrimary
Other Departments & Organizations
- Genetics
Education & Training
- PhD
- University of Barcelona, Biomedicine (2011)
- BSc
- Autonomous University of Barcelona, Biochemistry (2004)
- BSc
- University of Alicante, Biology (2002)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of María José Ortuño Romero's published research.
Publications Timeline
A big-picture view of María José Ortuño Romero's research output by year.
Marc Schneeberger Pane, PhD
6Publications
Publications
2021
Melanocortin 4 receptor stimulation prevents antidepressant-associated weight gain in mice caused by long-term fluoxetine exposure.
Ortuño MJ, Schneeberger M, Ilanges A, Marchildon F, Pellegrino K, Friedman JM, Ducy P. Melanocortin 4 receptor stimulation prevents antidepressant-associated weight gain in mice caused by long-term fluoxetine exposure. The Journal Of Clinical Investigation 2021, 131 PMID: 34673574, PMCID: PMC8670849, DOI: 10.1172/JCI151976.Peer-Reviewed Original Research
2016
Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect.
Ortuño MJ, Robinson ST, Subramanyam P, Paone R, Huang YY, Guo XE, Colecraft HM, Mann JJ, Ducy P. Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect. Nature Medicine 2016, 22: 1170-1179. PMID: 27595322, PMCID: PMC5053870, DOI: 10.1038/nm.4166.Peer-Reviewed Original Research
2013
How understanding gut serotonin secretion could potentially lead to new treatments for osteoporosis.
Ortuño MJ, Ducy P. How understanding gut serotonin secretion could potentially lead to new treatments for osteoporosis. Expert Review Of Endocrinology & Metabolism 2013, 8: 93-95. PMID: 30736168, DOI: 10.1586/eem.12.80.Peer-Reviewed Original ResearchOsterix induces Col1a1 gene expression through binding to Sp1 sites in the bone enhancer and proximal promoter regions.
Ortuño MJ, Susperregui AR, Artigas N, Rosa JL, Ventura F. Osterix induces Col1a1 gene expression through binding to Sp1 sites in the bone enhancer and proximal promoter regions. Bone 2013, 52: 548-56. PMID: 23159876, DOI: 10.1016/j.bone.2012.11.007.Peer-Reviewed Original Research
2010
p38 regulates expression of osteoblast-specific genes by phosphorylation of osterix.
Ortuño MJ, Ruiz-Gaspà S, Rodríguez-Carballo E, Susperregui AR, Bartrons R, Rosa JL, Ventura F. p38 regulates expression of osteoblast-specific genes by phosphorylation of osterix. The Journal Of Biological Chemistry 2010, 285: 31985-94. PMID: 20682789, PMCID: PMC2952199, DOI: 10.1074/jbc.M110.123612.Peer-Reviewed Original Research
2008
BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38.
Ulsamer A, Ortuño MJ, Ruiz S, Susperregui AR, Osses N, Rosa JL, Ventura F. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. The Journal Of Biological Chemistry 2008, 283: 3816-26. PMID: 18056716, DOI: 10.1074/jbc.M704724200.Peer-Reviewed Original Research